Boehringer Ingelheim, Evotec and BioMérieux Link on AMR

German biopharma Boehringer Ingelheim, compatriot CDMO Evotec and French diagnostics firm BioMérieux have formed a joint venture to develop a new approach to fight the rise of antibiotic-resistant infections.

© Shutterstock
© Shutterstock

The new company, called Aurobac Therapeutics, will be headquartered in Lyon, France. Boehringer Ingelheim is the lead investor with €30 million, with Evotec and BioMérieux each investing €5 million. The partners did not disclose the size of their stakes in the venture.

“The rise of antibiotic-resistant infections — also called antimicrobial resistance, or AMR — is indeed a looming global crisis,” added Michel Pairet, head of Boehringer Ingelheim’s Innovation unit and member of the board of managing directors. “Antibiotic resistance kills about 1.27 million people globally every year and it has been estimated that by 2050, as many as 10 million worldwide deaths could result from AMR, making it potentially deadlier than cancer.”

The partners said current antibiotic treatment regimens lean heavily on broad-spectrum and unfocused medicines. Aurobac’s goal is to change this to a precision-led approach, using new highly effective and targeted therapies, combined with rapid diagnostics to quickly identify pathogens and their resistance patterns.

Author: Elaine Burridge, Freelance Journalist

Company

Logo:

Boehringer Ingelheim

Binger Str. 173
55218 Ingelheim

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

most read

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.